This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

DuPont Sale Adds to Dow Index Dieting

NEW YORK ( TheStreet) -- The Dow Jones Industrial Average is on a diet.

In announcing a $4.9 billion sale of its automotive coating unit to private equity firm Carlyle Group (CG - Get Report) -- one of the biggest private equity deals of 2012 -- DuPont (DD - Get Report) joins a growing list of Dow Jones Industrial Average giants who are undergoing asset sales and spinoffs.

Already in the last year, Dow leaders like Pfizer (PFE - Get Report), Kraft Foods (KFT) and ConocoPhillips (COP - Get Report) have either completed or are in the process of multi-billion dollar asset sales and spinoffs.

Now DuPont joins its slimming down Dow brethren with the sale of its performance coatings unit, which is expected to draw in $4 billion in 2012 revenue, roughly 10% of overall sales at the industrial giant.

The Carlyle Group is buying the unit, which is a supplier of vehicle and industrial coatings, in a bet on emerging market auto sales and the unit's established brands and technologies.

"DuPont Performance Coatings is a technology innovator and we look forward to building on its strong market presence to accelerate growth in emerging markets, particularly in China and Brazil," said Gregor Böhm, a managing director and co-head of Carlyle's Europe Buyout team, in a statement.

The deal will be funded by the firm's Carlyle Partners V and Carlyle Europe Partners III funds.

In 2012 results, DuPont said it will report performance coating division earnings as discontinued operations. It expects 2012 earnings from discontinued operations to be in the range of 41 cents to 47 cents per share, according to a press release. DuPont also left its full year earnings guidance unchanged on Thursday.

Wilmington, Del.-based DuPont said it is selling its coating unit as part of a focus on high-growth, high profit-margin operations in agriculture, materials and biotechnology. "We have determined that DPC's full growth potential would be best realized outside DuPont and through the sale to Carlyle," DuPont chief executive Ellen Kullman said in a statement.

The Dow diet of spinoffs and asset sales will be a key driver of overall M&A and IPO activity in what has been a lackluster year for deals.

ConocoPhillips spun its refining unit, Phillips 66 (PSX), in a May initial public offering that now stands at a market cap of over $26 billion.

Meanwhile, Pfizer's $11.85 billion sale of its baby nutrition unit to Nestle and its proposed spinoff of its animal health unit through an IPO are among the largest deals of 2012. Kraft and Pfizer are expected to IPO units in coming quarters.

For Carlyle Group, its acquisition of DuPont's performance coatings unit adds to previous bets tied to the automotive sector. The private equity giant also has investments in Allison Transmission (ALSN) and Hertz (HTZ), by way of previous buyouts.

Separately, in a Thursday filing with the Securities and Exchange Commission, Carlyle Group said that executives of the private equity fund have contributed $700 million to a new flagship buyout fund that it hopes will swell to $10 billion, according to Bloomberg. As the fund gobbles up assets, don't be surprised if more Dow dishes are brought to the deals table.

-- Written by Antoine Gara in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CG $26.98 0.00%
COP $62.93 0.00%
DD $71.65 0.00%
PFE $34.53 0.00%
AAPL $123.25 0.00%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs